
Passive Cardioid Technology
Fulcrum’s latest innovation, their patented Passive Cardioid Technology, was developed to overcome the excessive rear low frequency (LF) radiation that is a major performance challenge of many loudspeakers.



The subcardioid behavior of Fulcrum Acoustic’s patented loudspeakers is produced by a meticulously conceived acoustical circuit which balances the position of the low frequency driver, the enclosure depth and volume, and a unique arrangement of acoustical elements including rear-mounted ports and calibrated resistive elements.
Passive cardioid technology achieves impressive directional control mechanically within the enclosure in less than half the space required for active cardioid array systems. This allows for cardioid performance in applications that might not otherwise have the budget or space to accommodate an active cardioid array. Our single-amplified, full-range passive cardioid speakers also deliver system cost benefits over traditional bi-amplified active cardioid speaker arrays by enabling up to eight speakers to be driven by a single amplifier channel.
Passive Cardioid Technology was first introduced in Fulcrum's FL283 Line Array Module, is the basis for our Cardioid Subwoofers product line, and is a technology we continuously develop and evolve into new applications.
Passive Cardioid Speakers Explained
David W. Gunness, Fulcrum Acoustic co-founder and vice president of R&D, was awarded a U.S. patent, formally titled “Passive Cardioid Speaker, No. 10,123,111 B2”, on November 6, 2018. Linked here, Gunness addresses common questions regarding Fulcrum’s innovative new technology.